analysis for NCT00514683 [clinicaltrials_resource:NCT00514683/analysis/02ace926cf7216546b0ec9b1ca95aa26]
analysis [clinicaltrials_vocabulary:analysis]
analysis for NCT00514683 [clinicaltrials_resource:NCT00514683/analysis/02ace926cf7216546b0ec9b1ca95aa26]
Bio2RDF identifier
NCT00514683/analysis/02ace926cf7216546b0ec9b1ca95aa26
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ace926cf7216546b0ec9b1ca95aa26
ci lower limit [clinicaltrials_vocabulary:ci-lower-limit]
ci n sides [clinicaltrials_vocabulary:ci-n-sides]
ci percent [clinicaltrials_vocabulary:ci-percent]
ci upper limit [clinicaltrials_vocabulary:ci-upper-limit]
3.509999990463257e+0
dispersion type [clinicaltrials_vocabulary:dispersion-type]
Standard Error of the Mean
dispersion value [clinicaltrials_vocabulary:dispersion-value]
2.3299999237060547e+0
estimate desc [clinicaltrials_vocabulary:estimate-desc]
Mean difference to placebo is calculated. Negative change indicates worsening.
method [clinicaltrials_vocabulary:method]
method desc [clinicaltrials_vocabulary:method-desc]
ANCOVA with fixed terms for treatment, baseline, region.
non inferiority [clinicaltrials_vocabulary:non-inferiority]
p value [clinicaltrials_vocabulary:p-value]
6.442999839782715e-1
param type [clinicaltrials_vocabulary:param-type]
Mean Difference (Final Values)
param value [clinicaltrials_vocabulary:param-value]
identifier
clinicaltrials_resource:NCT00514683/analysis/02ace926cf7216546b0ec9b1ca95aa26
title
analysis for NCT00514683
@en
type
label
analysis for NCT00514683 [clin ...... ce926cf7216546b0ec9b1ca95aa26]
@en